Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wednesday, June 12, 2013 - 12:40pm
tags:
FDA, diabetes, Merck, Januvia, Onglyza, Bristol-Myers Squibb, Byetta, AstraZeneca, Eli Lilly, Novo Nordisk, Victoza, Tradjenta, Boehringer Ingelheim
Juicy Dividends From the Three Pharmaceutical Giants
Motley Fool
Wednesday, June 12, 2013 - 12:36pm
tags:
dividends, Merck, Novartis, Pfizer
The First Real Cure in the $25 billion Asthma Market?
Motley Fool
Wednesday, June 12, 2013 - 12:35pm
tags:
asthma, dupilumab, Sanofi, Regeneron
IPE Kicks Off Phase-2 Clinical Trial for New Hypothyroid Drug
CP Wire
Wednesday, June 12, 2013 - 12:28pm
tags:
BCT303, clinical trials, IPE, hypothyroidism
Aveo defends kidney cancer drug rejected by the FDA
Boston Globe, MA
Wednesday, June 12, 2013 - 9:15am
tags:
kidney cancer, FDA, Aveo Oncology, tivozanib
OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed?
Seeking Alpha
Wednesday, June 12, 2013 - 9:13am
tags:
Ziopharm, OncoSec, IL-12, targeted delivery systems
Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha
Wednesday, June 12, 2013 - 9:07am
tags:
CO-1686, Clovis Oncology, non-small cell lung cancer
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wednesday, June 12, 2013 - 9:03am
tags:
biotech, Alkermes, Celgene, AstraZeneca, Coronado Biosciences, Dendreon, Incyte, Isis Pharmaceuticals, JNJ, Eli Lilly, Merck, Novavax, Novartis, Pfizer, Sangamo BioSciences, Pharmacyclics
Novo Nordisk Is An Undervalued Industry Leading Healthcare Company
Seeking Alpha
Wednesday, June 12, 2013 - 8:53am
tags:
Novo Nordisk
New Data Improves Sales Outlook For Celgene's Apremilast
TheStreet.com
Wednesday, June 12, 2013 - 8:52am
tags:
Celgene, apremilast, JNJ, Amgen, AbbVie, psoriatic arthritis
Pfizer wins $2.15 bln settlement from Teva and Sun
Marketwatch
Wednesday, June 12, 2013 - 8:51am
tags:
Pfizer, Teva, Sun Pharma, patents, generics, Protonix
Why Aegerion Is Worth 1,732 Times Sales
Seeking Alpha
Wednesday, June 12, 2013 - 8:50am
tags:
Aegerion, Juxtapid
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
Seeking Alpha
Wednesday, June 12, 2013 - 8:49am
tags:
Rockwell Medical, chronic kidney disease
[video]The Obesity-Drug Wars Officially Begin
Motley Fool
Tuesday, June 11, 2013 - 10:48pm
tags:
obesity, Arena Pharmaceuticals, Belviq, Qsymia, Vivus
J&J's Stelara effective in psoriatic arthritis trial
Reuters
Tuesday, June 11, 2013 - 10:45pm
tags:
JNJ, Stelara, psoriatic arthritis
Blue Belt touts FDA win for Stride knee implant
Mass Device
Tuesday, June 11, 2013 - 10:44pm
tags:
Blue Belt, FDA, knee, implants, devices
Histogenics appoints a new CEO | Personnel Moves
Mass Device
Tuesday, June 11, 2013 - 10:43pm
tags:
Histogenics, CEO, Management, devices
Vision: WaveTec raises $11M for cataract surgery tech
Mass Device
Tuesday, June 11, 2013 - 10:42pm
tags:
WaveTec, surgical, devices, funding
GE Healthcare launches $2B software-development program
Mass Device
Tuesday, June 11, 2013 - 10:42pm
tags:
GE Healthcare, devices, software, technology, development
CryoLife lands another win for its HeRo line
Mass Device
Tuesday, June 11, 2013 - 10:41pm
tags:
Cryolife, HeRo, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.